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Basic Sciences
Critical Roles of Macrophages in the Formation of
Intracranial Aneurysm
Yasuhisa Kanematsu, MD, PhD; Miyuki Kanematsu, MD; Chie Kurihara, BS;
Yoshiteru Tada, MD, PhD; Tsung-Ling Tsou, BS; Nico van Rooijen, PhD; Michael T. Lawton, MD;
William L. Young, MD; Elena I. Liang, BS; Yoshitsugu Nuki, MD, PhD; Tomoki Hashimoto, MD
Background and Purpose—Abnormal vascular remodeling triggered by hemodynamic stresses and inflammation is
believed to be a key process in the pathophysiology of intracranial aneurysms. Numerous studies have shown infiltration
of inflammatory cells, especially macrophages, into intracranial aneurysmal walls in humans. Using a mouse model of
intracranial aneurysms, we tested whether macrophages play critical roles in the formation of intracranial aneurysms.
Methods—Intracranial aneurysms were induced in adult male mice using a combination of a single injection of elastase
into the cerebrospinal fluid and angiotensin II-induced hypertension. Aneurysm formation was assessed 3 weeks later.
Roles of macrophages were assessed using clodronate liposome-induced macrophage depletion. In addition, the
incidence of aneurysms was assessed in mice lacking monocyte chemotactic protein-1 (CCL2) and mice lacking matrix
metalloproteinase-12 (macrophage elastase).
Results—Intracranial aneurysms in this model showed leukocyte infiltration into the aneurysmal wall, the majority of the
leukocytes being macrophages. Mice with macrophage depletion had a significantly reduced incidence of aneurysms
compared with control mice (1 of 10 versus 6 of 10; P0.05). Similarly, there was a reduced incidence of aneurysms
in mice lacking monocyte chemotactic protein-1 compared with the incidence of aneurysms in wild-type mice (2 of 10
versus 14 of 20, P0.05). There was no difference in the incidence of aneurysms between mice lacking matrix
metalloproteinase-12 and wild-type mice.
Conclusions—These data suggest critical roles of macrophages and proper macrophage functions in the formation of
intracranial aneurysms in this model. (Stroke. 2011;42:173-178.)
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Potential roles of inflammation in the pathophysiology ofintracranial aneurysms—both ruptured and unruptured—
have been suggested by observational and genetic studies.1–6
Macrophage infiltration has been well documented in both
ruptured and unruptured intracranial aneurysms in hu-
mans.2,3,7 A higher degree of inflammation in aneurysms
seems to be associated with aneurysmal wall destruction and
rupture.3,7
We have recently showed that macrophages and macro-
phage-derived cytokines are critical for hemodynamically
induced outward vascular remodeling.8,9 Vascular remodel-
ing coupled with inflammation is considered a key part in the
pathophysiology of intracranial aneurysms.4,10 Sustained vas-
cular remodeling may lead to aneurysmal growth and rup-
ture.1,11 By mediating inflammation and hemodynamically
induced vascular remodeling, macrophages may play critical
roles in the development, growth, and rupture of intracranial
aneurysms.
In this study, we examined whether macrophages are
critical for the formation of intracranial aneurysms using a
mouse model of intracranial aneurysms that replicates key
features of human intracranial aneurysms. First, we assessed
the effects of macrophage depletion by clodronate liposome
on the formation of aneurysms. Second, aneurysm formation
was assessed in mice lacking monocyte chemotactic protein-1
(MCP-1, CCL2). MCP-1 is a chemotactic factor that is
critical for proper macrophage functions. MCP-1 knockout
mice have reduced macrophage/monocyte counts and im-
paired macrophage functions. Therefore, they have been used
as a genetic equivalent of mice with pharmacological deple-
tion of macrophages and monocytes in various physiological
and pathological settings.12,13
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Materials and Methods
Experiments were conducted in accordance with the guidelines
approved by the University of California, San Francisco, Institutional
Animal Care and Use Committee.
We used the elastase-induced intracranial aneurysms in 8- to
9-week-old hypertensive mice as previously described.11 In this
model, two well-known clinical factors associated with human
intracranial aneurysms—hypertension and the disruption of elastic
lamina—were combined to induce intracranial aneurysm formation
in mice. We performed a single stereotaxic injection of elastase into
the cerebrospinal fluid at the right basal cistern. A volume of 2.5 L
elastase solution (17 mU) was injected at a rate of 0.2 L/min
(Ultramicropump; World Precision Instruments). Hypertension was
induced by a continuous subcutaneous infusion of angiotensin II at
1000 ng/kg/min for 3 weeks through an implanted osmotic pump
(Alzet pump; Durect).11,14
Systolic blood pressure was measured in mice before treatment, 1
week after elastase injection, and 2 weeks after elastase injection
using the tail cuff method. After 3 weeks, we euthanized the mice
and perfused the animals with bromophenol blue dye. Two blinded
observers assessed the formation of intracranial aneurysms by examin-
ing the circle of Willis and its major branches under a dissecting
microscope (10). Intracranial aneurysms were operationally defined as
a localized outward bulging of the vascular wall in the circle of Willis
or in its major primary branches, as previously described.10,11 After
inspecting the circle of Willis, the whole brain samples were frozen for
immunohistochemical staining.
Macrophage Depletion
Macrophage depletion was achieved by an intravenous injection of
liposome-encapsulated dichloromethylene diphosphonate (clodr-
onate liposome).15 We used 8- to 9-week-old male C57BL/6J mice
(n10 in each group). Clodronate was a gift from Roche Diagnostics
GmbH (Mannheim, Germany). Animals received clodronate lipo-
some intravenously 2 days before elastase and angiotensin II
treatment. This regimen was reported to cause a reduction of
macrophages to 10% of the baseline count.9,16 Animals in the
control group received the same volume of phosphate-buffered
saline-containing liposome (PBS liposome). We assessed the effi-
ciency of macrophage depletion by examining macrophages in the
spleen using immunohistochemistry, as previously described.9,16
Incidence of Aneurysms in MCP-1 Knockout Mice
and Matrix Metalloproteinase-12 Knockout Mice
In addition, the incidence of aneurysms was assessed in MCP-1
knockout mice and matrix metalloproteinase-12 (MMP-12) knock-
out mice (n10). Wild-type mice with the same background (both
C57BL/6J) were used as control mice (n20).
Immunohistochemical Analysis
Details of immunohistochemical analysis are described in the Sup-
plemental Data (available at http://stroke.ahajournals.org).
Statistical Analysis
All results were expressed as meanSD. Differences between
multiple groups were analyzed by 1-way analysis of variance
followed by the Tukey-Kramer post hoc test. Fisher exact test was
used to analyze the incidence of aneurysms. Statistical significance
was taken at P0.05.
Results
Presence of Macrophages in Experimental
Intracranial Aneurysm
Figure 1 shows representative intracranial aneurysms in
hypertensive mice that received a single injection of elastase
into the cerebrospinal fluid. Large saccular aneurysm forma-
tion was found along the circle of Willis or its major
branches, which is consistent with our previous study (Figure
1A–D).11 Most aneurysms were 250 m in diameter,
approximately 2 to 5 times larger than their parent arteries, as
we previously reported (Figure 1A–D). Some mice had
multiple aneurysms (Figure 1D).
A cerebral artery from the sham operation group revealed
an endothelial cell lining with a thin layer of smooth muscle
cells, as previously described (Figure 2A).11 In contrast,
intracranial aneurysms had a partially thickened vascular wall
with inflammatory cell infiltration (Figure 2B). Endothelial
cell layers seemed to be generally intact, but smooth muscle
cell layers had thickened in the area with intense inflamma-
tory cell infiltration.
Pan-leukocyte staining using anti-CD45 antibody and mac-
rophage staining using anti-CD68 antibody in the cerebral
artery from the sham operation group showed a lack of
inflammatory cells and macrophage infiltration (Figures 2C
and 2E). In intracranial aneurysms, numerous leukocytes
(CD45-positive cells) were detected in the adventitia and
Figure 1. Representative intracranial aneurysms in
hypertensive mice that received a single injection
of elastase into the cerebrospinal fluid. Arrows
indicate aneurysms. Large aneurysm formation
was found along the circle of Willis and its major
branches (A–D). Dissection of aneurysms revealed
the saccular shape of the aneurysms (A–B). Some
of the mice had multiple aneurysms (D).
Bar1 mm. ACA indicates anterior cerebral artery;
MCA, middle cerebral artery; PCA, posterior cere-
bral artery; ICA, internal carotid artery.
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media of the aneurysmal wall (Figure 2D), especially in the
thickened part of aneurysmal wall, which is generally consistent
with observations in human intracranial aneurysms.2,3,7 Macro-
phage staining showed macrophage infiltration into the an-
eurysmal wall with a distribution similar to that of leukocytes
(Figure 2F–G). Double staining with anti-CD68 and anti-
CD45 revealed that the majority of leukocytes in intracranial
aneurysms in this model were macrophages (Figure 2H).
Effects of Macrophage Depletion on Intracranial
Aneurysm Formation
Ten mice underwent macrophage depletion treatment with
clodronate liposome 2 days before the induction of intracra-
nial aneurysms, and another 10 mice received PBS liposome.
All 20 mice received a single stereotaxic injection of elastase
into the cerebrospinal fluid to disrupt the elastic lamina and a
continuous infusion of angiotensin II to induce hypertension.
When we examined the mice 3 weeks after aneurysm
induction, mice that received macrophage depletion treatment
using clodronate liposome had a reduced incidence of intra-
cranial aneurysms compared with mice that received PBS
liposome (mice with intact macrophages; 1 of 10 versus 6 of
10; 10% versus 60%, P0.05; Figure 3A), indicating a
critical role of macrophages in the formation of intracranial
aneurysms in this model.
Although there were abundant macrophages in the intra-
cranial aneurysms from a PBS liposome-treated mouse (Fig-
ure 3D–E), middle cerebral arteries from mice in either the
sham operation group (Figure 3B–C) or the macrophage
depletion group (Figure 3F–G) did not show macrophage
infiltration into the vascular wall.
Quantification of macrophages (n5 in each group)
showed that the number of macrophages was higher in the
Figure 2. Hematoxylin and eosin, pan-
leukocyte, and macrophage staining. A,
Cerebral artery from a mouse in the sham
operation group showed an endothelial
cell lining with a thin layer of smooth
muscle cells. B, Intracranial aneurysms
had a partially thickened vascular wall
with inflammatory cell infiltration. Endo-
thelial cell layers seemed to be generally
intact, but smooth muscle cell layers had
thickened in the area with intense inflam-
matory cell infiltration. C, E, Cerebral
artery from a mouse in the sham opera-
tion group showed a lack of inflammatory
cells. D, G, Intracranial aneurysms had
numerous leukocytes. Distribution of
macrophages was similar to that of leuko-
cytes. F, Double staining with anti-CD68
and anti-CD45 revealed that a majority of
leukocytes in intracranial aneurysms in
this model were macrophages.
Figure 3. Macrophage depletion and
intracranial aneurysm formation. A, Mice
with macrophage depletion treatment
using clodronate liposome had a reduced
incidence of intracranial aneurysms com-
pared with mice that received PBS lipo-
some (P0.05). B–G, Whereas there was
an abundant number of macrophages in
the intracranial aneurysms from PBS
liposome-treated mice, middle cerebral
arteries from mice in either the sham
operation group or the macrophage
depletion group did not show macro-
phage infiltration into the vascular wall. H,
The number of macrophages was higher
in mice treated with elastase, angiotensin
II, and PBS liposome compared with mice
in the sham group or macrophage deple-
tion group (n5 in each group, P0.05).
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mice treated with elastase, angiotensin II, and PBS liposome
compared with mice in the sham group or macrophage
depletion group (0.50.3 versus 11.13.3, P0.05; 0.50.3
versus 1.00.3, P0.05; Figure 3H).
Immunohistochemical staining for CD68-positive cells
(monocyte/macrophage) in the spleen (n5 at each time
point) was used to assess the efficiency and time course of
clodronate liposome treatment as previously described (Fig-
ure 4A–B).9,16 Treatment with clodronate liposome decreased
the CD68-positive area in the spleen by 88% from the
baseline (28.84.1 versus 3.21.0%, P0.05), showing an
effective macrophage/monocyte reduction by the clodronate
treatment. At 2 weeks, the CD68-positive area returned to
baseline (28.84.1 versus 23.12.6%).
Angiotensin II treatment caused hypertension in both
groups. After 1 week and 2 weeks, systolic blood pressure
was higher than the baseline. Macrophage depletion treatment
did not affect systolic blood pressure (Figure 4C).
Reduced Incidence of Intracranial Aneurysm in
MCP-1 Knockout Mice
Because MCP-1 knockout mice have reduced monocyte/mac-
rophage counts and impaired macrophage functions,17 we
used MCP-1 knockout mice to further test the critical role of
macrophages in the formation of intracranial aneurysms.
Twenty wild-type mice and ten MCP-1 knockout mice
underwent intracranial aneurysm induction.
MCP-1 knockout mice had a lower incidence of aneurysms
compared with wild-type mice (2 of 10 versus 14 of 20; 20%
versus 70%, P0.05; Figure 5A). Immunohistochemical
staining of cerebral arteries for macrophages showed a lack of
macrophage infiltration in MCP-1 knockout mice (Figure
5B). Quantification of macrophages in the middle cerebral
artery (n5 in each group) showed reduced macrophage
infiltration to the middle cerebral artery in MCP-1 knockout
mice compared with macrophage infiltration in wild-type
mice (2.81.4 versus 10.90.8, P0.05; Figure 5E).
Macrophages produce MMPs that are critical for vascular
remodeling.8,9 Previously, we have shown there is high
activity of MMPs in intracranial aneurysms using this mod-
el.11 The MMP inhibitor, doxycycline, significantly reduced
the incidence of intracranial aneurysms.11 MMP-9 knockout
mice, but not MMP-2 knockout mice, had a reduced inci-
dence of intracranial aneurysms.11 Whereas MMP-9 is the
main gelatinase produced by macrophages, MMP-12 repre-
sents the major elastase from macrophages. MMP-12 could
be the proteinase responsible for facilitating structural
changes of elastic lamina, resulting in physiological and
Figure 4. A, Macrophage staining of the spleen from mice that
received clodronate liposome. Brown area indicates the macro-
phage-positive area. B, Clodronate liposome treatment
decreased the CD68-positive area in the spleen by 88% from
baseline (P0.05), showing effective macrophage/monocyte
reduction by the clodronate treatment. At 2 weeks, the CD68-
positive area returned to baseline. C, Successful induction of
hypertension by angiotensin II.
Figure 5. A, MCP-1 knockout mice had a
lower incidence of aneurysms compared
with wild-type mice (P0.05). There was
no difference in the incidence of intracra-
nial aneurysms between MMP-12 knock-
out mice and wild-type mice. B–D,
Whereas macrophage infiltration was
observed in the cerebral arteries of wild-
type mice (B) and MMP-12 knockout
mice (D), cerebral arteries in MCP-1
knockout mice showed a lack of macro-
phage infiltration (C). F, Successful induc-
tion of hypertension by angiotensin II.
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pathological vascular remodeling.18 Therefore, we investi-
gated the roles of MMP-12 in the formation of intracranial
aneurysms. However, there was no difference in the inci-
dence of intracranial aneurysms between MMP-12 knockout
mice and wild-type mice (50% versus 70%). Moreover,
immunohistochemical staining for macrophages (CD68-
positive cells) showed a similar number of macrophages that
accumulated in MMP-12 knockout mice compared with the
number of macrophages in wild-type mice (9.42.3 versus
10.90.8; Figure 5E).
Continuous infusion of angiotensin II increased systolic
blood pressure from the baseline after 1 week and 2 weeks in
MCP-1 knockout mice and MMP-12 knockout mice. There
was no significant difference between wild-type mice and
MCP-1 or MMP-12 knockout mice at 1 week and 2 weeks
(Figure 5F).
Discussion
In this study, we have shown the critical roles of macrophages
in the formation of intracranial aneurysms in mice. We used
a recently developed intracranial aneurysm model in which
intracranial aneurysms were induced by a combination of
single stereotaxic injection of elastase into the cerebrospinal
fluid and pharmacologically induced hypertension in mice.
Intracranial aneurysms in this mouse model closely resemble
histological changes that are observed in human intracranial
aneurysms.11 Using this model, we first showed infiltration of
inflammatory cells, mostly macrophages, into the aneurysmal
wall. Second, mice with pharmacological depletion of mac-
rophages had a significantly reduced incidence of intracranial
aneurysms compared with mice with intact macrophages. In
addition, MCP-1 knockout mice, mice with reduced mono-
cyte/macrophage counts and impaired macrophage function,
had a significantly reduced incidence of intracranial aneu-
rysms compared with wild-type mice. These findings strongly
indicate that macrophages play critical roles in the formation
of intracranial aneurysms in this model, especially during the
early stages of aneurysmal formation and growth.
Intracranial aneurysms are commonly found in locations
where abnormal hemodynamic stresses are exerted on the
vascular wall.19 Abnormal hemodynamic stresses trigger an
inflammatory process by activating endothelial cells and
monocytes/macrophages. These cells secrete proteinases, in-
cluding MMPs and elastases.1 MMPs can destabilize the
vascular wall directly by facilitating vascular remodeling by
digestion of the vascular matrix and indirectly by activating
and releasing of other proteinases and angiogenic factors.20
We have previously shown critical roles of macrophages and
MMPs in adaptive vascular remodeling of large arteries.9
Intracranial aneurysms may represent a result of maladaptive
vascular remodeling in which inflammatory cells maintain
active and abnormal remodeling processes that lead to aneu-
rysm growth and rupture.1
Similar to our study, Aoki et al used MCP-1 knockout mice
in a different mouse intracranial aneurysm model in which
intracranial aneurysms were induced by a combination of 4
manipulations over 5 months: treatment with  aminopropi-
onitrile (irreversible lysyl oxidase inhibitor), unilateral ca-
rotid artery ligation, bilateral posterior renal artery ligation,
and high-salt drinking water.21 In their study, aneurysmal
changes, defined as disruption of elastic lamina with or
without the formation of aneurysms, were less frequent in
MCP-1 knockout mice compared with wild-type mice, which
is generally consistent with our data.21 In their study, there
was a weak trend for MCP-1 knockout mice to have a reduced
incidence of aneurysms compared with wild-type mice (10%
versus 20%), whereas our study showed a statistically signif-
icant reduction of the incidence of aneurysms in MCP-1
knockout mice compared with wild-type mice (20% versus
70%). Such difference between these two studies might be
due to a difference in severity of the phenotype between these
two models. Aneurysms induced by a single injection of
elastase into the cerebrospinal fluid in hypertensive mice tend
to be larger and macroscopically apparent.11 In contrast, the
mouse aneurysm model used by Aoki et al yielded smaller
aneurysms with more subtle histological changes.21,22
Previously, potential roles of MMPs were shown in the
formation of intracranial aneurysms.6,11,22 We have shown
that a broad-spectrum inhibitor of MMPs can suppress the
formation of intracranial aneurysms. Although MMP-2 was
not critical for the formation of intracranial aneurysms, mice
lacking MMP-9 had a reduced incidence of aneurysms.11
Macrophage-derived MMP-9 may be playing critical roles in
the formation of intracranial aneurysms.22 In this study, we
assessed roles of another key MMP that is produced by
macrophages—MMP-12, a macrophage elastase. However, a
lack of MMP-12 did not affect the incidence of aneurysms.
Unlike MMP-9, MMP-12 may not play a significant role in
the formation of intracranial aneurysms. Because exogenous
elastase was used to induce aneurysms in our model, it may
be the case that the early processes that require endogenous
elastases such as MMP-12 may have been bypassed in this
model. Alternatively, roles of macrophages and MMPs may
be different between different stages—early and late stages—
of aneurysm formation and growth.
Clodronate liposome, the treatment we used to deplete
macrophages, may have unknown side effects. However,
in our experiments, the animals that received clodronate
liposome did not show any apparent signs of adverse
effects. In our previous study, we have shown that clodr-
onate liposome treatment did not have effects on other
leukocyte subpopulation, platelets, or red blood cells.9 Our
methods to deplete macrophages did not completely de-
plete the target cell population. This may have resulted in
an incomplete suppression of aneurysm formation. Alter-
natively, other cell types may have had compensated for
the relative lack of macrophages.
In summary, data from this study strongly indicated critical
roles of macrophages in the formation of intracranial aneu-
rysms in mice. Macrophages and macrophage-derived cyto-
kines may be maintaining abnormal and active aneurysmal
wall remodeling that lead to aneurysmal growth and rupture.
Pharmacological therapy that modifies inflammation medi-
ated by macrophages may be studied for the prevention of
progression, growth, and rupture of intracranial aneurysms.
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2Immunohistochemical analysis
Immunohistochemical staining was performed using rat monoclonal anti mouse
CD45 for pan-leukocytes and rat monoclonal anti mouse CD68 for macrophages
as previously described.1  Representative aneurysms from the wild-type mice
that received elastase and angiotensin-II treatment and control middle cerebral
artery (immediately distal of the bifurcation from the internal carotid artery) from
the wild-type mice that received a stereotaxic injection of PBS and a continuous
infusion of PBS through osmotic pump were used to identify inflammatory cell
types that infiltrated into aneurysms.
        For quantification of macrophages infiltration into cerebral arteries, an
additional five mice in each group (clodronate liposome, PBS liposome, MCP-1
knockout mice, MMP-12 knockout mice, and wild-type mice) were sacrificed one
week after aneurysm induction. One cross-sectional slice of the middle cerebral
artery, immediately distal of the bifurcation from the internal carotid artery, from
each mouse was used. Two blinded observers independently performed
quantitative analysis as previously described.1 Macrophages were counted under
high magnification (400x) in a randomly selected area of each quadrant of the
cross-section of the middle cerebral artery. The arterial area per field was
measured by using ImageJ software (National Institutes of Health). The number
of macrophages per area of 0.01 square millimeters was calculated using the
following formula: number of positive cells per field / arterial area per field.
Results from the two observers were averaged.
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